Italia markets close in 26 minutes

Aclaris Therapeutics, Inc. (0H8T.L)

LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
18,43+2,26 (+13,97%)
Al 06:35PM BST. Mercato aperto.
Schermo intero
Chiusura precedente16,17
Aperto18,43
Denaro0,00 x N/D
Lettera0,00 x N/D
Min-Max giorno18,43 - 18,43
Intervallo di 52 settimane18,43 - 18,43
Volume5
Media VolumeN/D
Capitalizzazione5,389M
Beta (5 anni mensile)0,62
Rapporto PE (ttm)N/D
EPS (ttm)-1,36
Prossima data utili31 ott 2022 - 04 nov 2022
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Aclaris Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update

    •Appointed Douglas Manion, M.D., FRCP (C), as President and COO •Initiated Phase 2a Study Activities for Psoriatic Arthritis WAYNE, Pa., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced its financial results for the second quarter of 2022 and provided a corporate update. “It has been a busy first half of the year as we continue in ou

  • GlobeNewswire

    Aclaris Therapeutics Expands Leadership Team

    Appoints Douglas Manion, M.D., FRCP (C), as President and COO WAYNE, Pa., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced the appointment of Douglas Manion, M.D., FRCP (C), as President and Chief Operating Officer. Dr. Manion will be responsible for overseeing day-to-day operations, continuing to develop Aclaris’ infrastructure and

  • GlobeNewswire

    Aclaris Therapeutics to Participate in the Jefferies Healthcare Conference

    WAYNE, Pa., June 01, 2022 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that Dr. Neal Walker, President and CEO of Aclaris, will participate in a fireside chat at the Jefferies Healthcare Conference on Wednesday, June 8, 2022 at 11:30 a.m. ET in New York, New York. Management will be available June 8th for 1x1 meetings. A live webcast of the fi